More than 80 Weill Cornell Medicine students, faculty and senior leadership gathered Oct. 7 at Weill Cornell Medicine for a ribbon-cutting ceremony for the Feil Family Student Center, which occupies renovated first and second floors in the main campus buildings on York Avenue. The state-of-the-art center was made possible by a $12.5 million gift from the Feil Family.
Weill Cornell Medicine hosted the first-ever National Conference on Medical Student Mental Health and Well-Being Sept. 18-19, in partnership with the Association of American Medical Colleges, Associated Medical Schools of New York and the American Foundation for Suicide Prevention,
A transformative new scholarship program established by Weill Cornell Medicine will eliminate medical education debt for all students who qualify for financial aid.
A team of scientists from Weill Cornell Medicine and The Rockefeller University has illuminated the basic mechanism of Piezo proteins, which function as sensors in the body for mechanical stimuli such as touch, bladder fullness and blood pressure.
Four distinguished Weill Cornell Medicine physician-scientists – Drs. Silvia Formenti, Barbara Hempstead, Lisa Newman and Laura Riley – have been selected as Crain’s Notable Women in Healthcare in New York City.
A molecule best known for its association with migraines may be a key to new treatments for common worm infections as well as allergic inflammatory disorders such as asthma, according to a study from scientists at Weill Cornell Medicine and the National Institutes of Health.
Dr. Juan Cubillos-Ruiz got his first look at ovarian cancer early in his doctoral research, which focused on understanding how the microenvironment of a tumor affects a patient’s immune system.
The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.
Matthew Laghezza, chief physician assistant in the Department of Emergency Medicine at Weill Cornell Medicine and the Lisa Perry Emergency Center at NewYork-Presbyterian/Weill Cornell Medical Center, was named 2018 Emergency Medicine Physician Assistant of the Year by the Society of Emergency Medicine Physician Assistants.
A new technology devised by scientists at Weill Cornell Medicine and the New York Genome Center (NYGC) enables the measurement of gene mutations and their effects on gene activity within individual cancer cells biopsied from patients.
The Executive M.B.A./M.S. in Healthcare Leadership program, offered jointly by the Weill Cornell Graduate School of Medical Sciences and Cornell’s Samuel Curtis Johnson Graduate School of Management in May celebrated a milestone: graduating its first class of 39 students.
More than 370 students celebrated a milestone on May 30: graduating from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences and Weill Cornell Medicine-Qatar.
On the eve of their commencement, students from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences were recognized for their outstanding achievements.
Dr. Katharine Hsu, M.D. ’94, Ph.D. ’93, professor of medicine and attending physician at Memorial Sloan Kettering Cancer Center, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.
The event, sponsored by the institution’s BioVenture eLab, is the culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.
Dr. Matthew Greenblatt, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded the 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research to support his work studying tumor growth in bone.
The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.
A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers.
![The company Iris takes first prize in the $100,000 Biomedical Business Plan Challenge. Team members from left to right: Drs. Rochelle Joly, Alison Herman, Meghan Reading Turchioe, Jyotishman Pathak, and graduate student Andrea Cohen. [Not pictured:Dr. Yiye Zhang]. All photos: Ashley Jones.](https://news.weill.cornell.edu/sites/default/files/styles/news_story_featured_image/public/story_featured_images/wcm_biomed_business_challenge_2019_156.png?itok=Tjhm1htz&c=7f335e93d1589899f01ad9bc2c8c1401)
